Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.

Win KT, Lee SW, Huang HY, Lin LC, Lin CY, Hsing CH, Chen LT, Li CF.

Tumour Biol. 2013 Dec;34(6):3923-31. doi: 10.1007/s13277-013-0980-z. Epub 2013 Jul 11.

PMID:
23838801
2.

Expression of cyclin-dependent kinase 2-associated protein 1 confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study.

Wu LC, Chen YL, Wu WR, Li CF, Huang HY, Lee SW, Chang SL, Lin CY, Chen YH, Hsu HP, Lu PJ, Shiue YL.

J Clin Pathol. 2012 Sep;65(9):795-801. doi: 10.1136/jclinpath-2012-200893. Epub 2012 Jul 12.

PMID:
22791769
3.

Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.

Kim J, Hong SJ, Lim EK, Yu YS, Kim SW, Roh JH, Do IG, Joh JW, Kim DS.

J Exp Clin Cancer Res. 2009 Feb 16;28:20. doi: 10.1186/1756-9966-28-20.

4.

Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma.

Ma LJ, Lee SW, Lin LC, Chen TJ, Chang IW, Hsu HP, Chang KY, Huang HY, Li CF.

Tumour Biol. 2014 Feb;35(2):1703-12. doi: 10.1007/s13277-013-1235-8. Epub 2013 Oct 1.

PMID:
24081675
5.

Cyclin-dependent kinase 4 overexpression is mostly independent of gene amplification and constitutes an independent prognosticator for nasopharyngeal carcinoma.

Chen TJ, Lee SW, Lin LC, Lin CY, Chang KY, Li CF.

Tumour Biol. 2014 Jul;35(7):7209-16. doi: 10.1007/s13277-014-1884-2. Epub 2014 Apr 27.

PMID:
24771220
6.

Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma.

Tai HC, Huang HY, Lee SW, Lin CY, Sheu MJ, Chang SL, Wu LC, Shiue YL, Wu WR, Lin CM, Li CF.

J Clin Pathol. 2012 Mar;65(3):248-53. doi: 10.1136/jclinpath-2011-200413. Epub 2011 Nov 12.

PMID:
22081787
7.
8.

Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.

Aleskandarany MA, Rakha EA, Ahmed MA, Powe DG, Ellis IO, Green AR.

Breast Cancer Res Treat. 2011 Jun;127(2):407-16. doi: 10.1007/s10549-010-1012-y. Epub 2010 Jul 9.

PMID:
20617378
9.

Nicotinamide N-methyltransferase protein expression in renal cell cancer.

Zhang J, Xie XY, Yang SW, Wang J, He C.

J Zhejiang Univ Sci B. 2010 Feb;11(2):136-43. doi: 10.1631/jzus.B0900249.

10.

AMACR overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.

Lee YE, He HL, Lee SW, Chen TJ, Chang KY, Hsing CH, Li CF.

Tumour Biol. 2014 Aug;35(8):7983-91. doi: 10.1007/s13277-014-2065-z. Epub 2014 May 16.

PMID:
24833092
11.

Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma.

Xie X, Wang H, Jin H, Ouyang S, Zhou J, Hu J, Xi X, Luo J, Zhang Y, Hu B.

Radiat Oncol. 2013 May 11;8:117. doi: 10.1186/1748-717X-8-117.

12.

Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.

Yip PY, Cooper WA, Kohonen-Corish MR, Lin BP, McCaughan BC, Boyer MJ, Kench JG, Horvath LG.

J Clin Pathol. 2014 Apr;67(4):333-40. doi: 10.1136/jclinpath-2013-201870. Epub 2013 Nov 21.

PMID:
24265323
13.

Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.

He HL, Lee YE, Shiue YL, Lee SW, Lin LC, Chen TJ, Wu TF, Hsing CH, Huang HY, Wang JY, Li CF.

J Surg Oncol. 2014 Dec;110(8):1002-10. doi: 10.1002/jso.23764. Epub 2014 Aug 22.

PMID:
25155043
14.

Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer.

Andre F, Nahta R, Conforti R, Boulet T, Aziz M, Yuan LX, Meslin F, Spielmann M, Tomasic G, Pusztai L, Hortobagyi GN, Michiels S, Delaloge S, Esteva FJ.

Ann Oncol. 2008 Feb;19(2):315-20. Epub 2007 Sep 5.

15.

TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma.

Lan J, Huang HY, Lee SW, Chen TJ, Tai HC, Hsu HP, Chang KY, Li CF.

Tumour Biol. 2014 Jan;35(1):179-87. doi: 10.1007/s13277-013-1022-6. Epub 2013 Jul 30.

PMID:
23897556
16.

Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy.

Shi Y, Chen L, Li J, Lv YL, Sun Q, Wang LX, Jiao SC.

Tumour Biol. 2011 Apr;32(2):381-90. doi: 10.1007/s13277-010-0131-8. Epub 2010 Nov 18.

PMID:
21086091
17.

Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.

Sheu MJ, Li CF, Lin CY, Lee SW, Lin LC, Chen TJ, Ma LJ.

Tumour Biol. 2014 Aug;35(8):7755-63. doi: 10.1007/s13277-014-2032-8. Epub 2014 May 9.

PMID:
24810927
18.
19.

Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma.

Watzka SB, Setinek U, Stubenberger EB, Tötsch M, Dekan G, Marcher M, Fleck T, Müller MR.

Eur J Cardiothorac Surg. 2011 Feb;39(2):180-4. doi: 10.1016/j.ejcts.2010.05.007. Epub 2010 Jul 1. Erratum in: Eur J Cardiothorac Surg. 2012 May;41(5):1222.

PMID:
20580243
20.

Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test.

Sartini D, Muzzonigro G, Milanese G, Pozzi V, Vici A, Morganti S, Rossi V, Mazzucchelli R, Montironi R, Emanuelli M.

Cell Biochem Biophys. 2013 Apr;65(3):473-83. doi: 10.1007/s12013-012-9451-1.

PMID:
23097023
Items per page

Supplemental Content

Write to the Help Desk